Preview
Description
In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have been developed. These therapies include anti-CD20 antibodies and chimeric antigen receptor T-cell (CAR-T) therapies. With continued developments in NHL management, bispecific antibodies are a promising strategy for use in the relapsed/refractory setting with promising data showing potential for improving outcomes in patient care.
Technical Analysis
Package Overview Basic metadata
Bundle ID
com.mlg.nhlar Current Version 1.0
Minimum iOS 11.0
Package Size App Store Size
Package Metadata 0 / 1 version records
Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.
Developer Information
Known Version Records
0 version records with stored package metadata • 1 known version records
Stored metadata does not guarantee a package is currently available to download.
| Details | Version / IDs | Version date | Action |
|---|---|---|---|
| Not archived | App Store ID: 857352619 | Unknown | Request Version |